Novo Nordisk sues Hims & Hers over compounded obesity drugs
Nordisk on Monday said he is suing an online telehealth provider him and her to mass market cheaper, unapproved copies…
Novo Nordisk A/S
FDA Says Novo Nordisk Anti-Obesity Pill TV Ad Includes Misleading Claims
Still life of the new Wegovy semaglutide tablets on a white background. It is a prescription medication used with a…
Hims & Hers pulls knockoff weight-loss pill after legal threats
Piotr Swat | Light rocket | fake images him and her on Saturday said it will pull its knock-off weight-loss…
Eli Lilly (LLY) Earnings in Q4 2025
Eli Lilly on Wednesday released fourth-quarter earnings, revenue and 2026 guidance that beat estimates, as demand soars for its blockbuster…
White House launches direct-to-consumer drug site
President Donald Trump makes an announcement from the Oval Office of the White House in Washington, November 6, 2025. Jonathan…
Eli Lilly Wins in LPG-1 Market Over Novo Nordisk, Earnings Show
The Eli Lilly and Novo Nordisk logos. Mike Blake | Little Tom | Reuters It's the story of two drugmakers…
Pfizer's monthly anti-obesity shot shows promise in trial
Smith Collection | Stock Photos | fake images Pfizer on Tuesday said its experimental anti-obesity drug, which it acquired through…
Eli Lilly CEO David Ricks Discusses Medicare Coverage of Obesity Pills
Eli Lilly Chief Executive Dave Ricks said Friday that upcoming Medicare coverage of obesity drugs could be a major catalyst…
Eli Lilly plans $3.5 billion plant in Pennsylvania for obesity drugs
Eli Lilly Chairman and CEO Dave Ricks speaks during a news conference in Houston, Sept. 23, 2025. Antranik Tavitian |…
Structure Therapeutics CEO talks obesity pill and more
Ray Stevens, CEO of Structure Therapeutics Inc., during a Bloomberg Television interview at the JPMorgan Healthcare Conference in San Francisco,…